Product Highlight
Condition targeted:
Insomnia
How it works:
SleepQ implements CBT-I(Cognitive Behavioral Therapy for Insomnia) as an application to improve patient’s insomnia symptoms.
Impact:
SleepQ increased sleep efficiency of patients by 15.14%
Product Overview
Medical condition:
Insomnia (including chronic insomnia)
Target patient population:
Adult insomnia patients who desire clinical improvement of insomnia
What to expect:
SleepQ demonstrated improvement in Sleep Efficiency and other insomnia symptoms including Dysfunctional Beliefs and Attitudes about Sleep
Note: for more information, please visit https://www.weltcorp.com/
Clinical Overview
Indications for use:
SleepQ is indicated to improve insomnia for patients 18 years of age or older.
Outcomes:
Clinical study demonstrated that patients improved on Sleep Efficiency by 15.14% using SleepQ.
Directions:
For Prescription Purpose:
Patient installs the SleepQ patient app on their own mobile device and enters the given access code. The patient can write a sleep diary, edit or view sleep information, and receive sleep restriction through “Recommended Time in Bed (R-TIB)” based on the sleep diary data patients entered. The patient receives sleep hygiene and stimulus control education and undergoes cognitive therapy for cognitive distortion related to sleep. Additionally, patients practice breathing exercise, muscle relaxation therapy, and visualization training.
Risks & warnings:
No adverse events were reported during the trial. Clinicians may evaluate patients’ medical condition to be inappropriate of usage, such as having major psychiatric illness, suicidal risk, occupational risk due to sleep restriction, shift workers.
Place in therapy:
Complementary to current therapy
Product Access
Product description:
SleepQ is a software as a medical device that implements CBT-I (Cognitive Behavioral Therapy for Insomnia) as an application to improve patients’ insomnia symptoms.
Prescription status:
A prescription from a qualified healthcare provider is required.
Patient access:
In South Korea, SleepQ can be used on a mobile device, i.e., smartphone with iOS or Android operating system. An access code is generated for patients after their healthcare provider completes a prescription.
Provider access:
Clinicians can access patient’s in-app data related to insomnia through Electronic Medical Record systems, including weekly reports (currently limited to certain clinics)
Coverage options:
In South Korea, SleepQ is not covered during the preliminary listing phase but the actual expense insurance cost may vary depending on each patient’s insurance coverage policy.
Product availability:
SleepQ is available in:
- South Korea: MFDS approval
Unique Features:
SleepQ provides personalized treatment based on sleep data with motivation system and comprehensive solutions. It also provides dashboard accessible to HCP easily integrated within current medical workflow.
Clinical Trials
The provided set of evidence represents a sample of conducted studies. For a comprehensive collection contact manufacturers directly.
- Study Title: A Randomized, Double-blinded, Sham-controlled Clinical Trial to Evaluate the Safety and Efficacy of Digital Cognitive Behavioral Therapy for Insomnia – under review for publication
Study Design: Randomized, Double-blinded, Sham-controlled Trial
Outcomes: 15.14% increase in sleep efficiency
Note: for more research, please visit https://clinicaltrials.gov/study/NCT05809544?intr=WELT-I&rank=2